Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-28T07:46:35.490Z Has data issue: false hasContentIssue false
  • English
  • Français

Lactic acidosis following intentional overdose by inhalation of salmeterol and fluticasone

Published online by Cambridge University Press:  11 May 2015

Alessandro Manara ,
Philippe Hantson ,
Dominique Vanpee  and
Frédéric Thys
Alessandro Manara*
Affiliation:
Department of Emergency Medicine, Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium
Philippe Hantson
Affiliation:
Department of Intensive Care, Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium
Dominique Vanpee
Affiliation:
Department of Emergency Medicine, Université Catholique de Louvain, Cliniques Universitaires de Mont-Godinne, Yvoir, Belgium
Frédéric Thys
Affiliation:
Department of Emergency Medicine, Université Catholique de Louvain, Cliniques Universitaires St-Luc, Brussels, Belgium
*
Department of Emergency Medicine, Université Catholique de Louvain, Cliniques Universitaires St-Luc, avenue Hippocrate 10, 1200 Brussels, Belgium; [email protected].

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Salmeterol, a long-acting β2-adrenergic receptor agonist used for the treatment of asthma and chronic obstructive pulmonary disease, has an adverse effects profile that is similar to that of salbutamol and other β2-agonists. We report a sympathomimetic syndrome with metabolic acidosis and hyperlactatemia after intentional inhalation of salmeterol in a suicide attempt. A 16-year-old female patient was admitted to the emergency department approximately 2 hours after having inhaled 60 puffs of a combination of salmeterol xinafoate 25 μg and fluticasone propionate 50 μg. She presented in an anxious state with complaints of palpitations and chest pain. The electrocardiogram demonstrated sinus tachycardia and ST-segment depression in the inferior and anterolateral leads. Laboratory findings showed hypokalemia, hypophosphatemia, and lactic acidosis. Cardiac troponin I and creatine kinase MB remained within the normal range. Treatment was supportive and included intravenous fluids and cautious potassium supplementation. The next day, electrocardiographic and laboratory findings returned to normal. We hypothesize that stimulation of β2-adrenergic receptors by inhalation of salmeterol caused this patient's lactic acidosis. This observation is consistent with the hypothesis that the hyperlactatemia observed during asthma attacks is due in part to the administration of high doses of β2-agonists. Salmeterol overdose by inhalation appears to be sufficient to cause lactic acidosis.

Keywords

hyperlactatemiametabolic acidosisoverdosesalmeterol
Type
Case Report • Rapport de cas
Information
Canadian Journal of Emergency Medicine , Volume 14 , Issue 6 , November 2012 , pp. 378 - 381
Copyright
Copyright © Canadian Association of Emergency Physicians 2012

References

REFERENCES

1.Cazzola, M, Testi, R, Matera, MG. Clinical pharmacokinetics of salmeterol. Clin Pharmacokinet 2002;41:19–30, doi:10.2165/00003088-200241010-00003.Google Scholar
2.Richards, SR, Chang, FE, Stempel, LE. Hyperlactacidemia associated with acute ritodrine infusion. Am J Obstet Gynecol 1983;146:1–5.Google Scholar
3.Rodrigo, GJ, Rodrigo, C. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma. Emerg Med J 2005;22:404–8, doi:10.1136/emj.2003.012039.CrossRefGoogle ScholarPubMed
4.Phillips, PJ, Vedig, AE, Jones, PL, et al. Metabolic and cardiovascular side effects of the beta2-adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol 1980;9:483–91.Google Scholar
5.Tobin, A, Pellizzer, A, Santamaria, JD. Mechanism by which systemic salbutamol increases ventilation. Respirology 2006;11:182–7, doi:10.1111/j.1440-1843.2006.00832.x.Google Scholar
6.Veenith, TV, Pearce, A. A case of lactic acidosis complicating assessment and management of asthma. Int Arch Med 2008;1:3.CrossRefGoogle ScholarPubMed
7.Manthous, CA. Lactic acidosis in status asthmaticus. Three cases and review of the literature. Chest 2001;119:1599–602, doi:10.1378/chest.119.5.1599.CrossRefGoogle ScholarPubMed
8.Jee, R, Brownlow, H. Hyperlactaemia due to nebulised salbutamol. Anaesthesia 2007;62:751–2, doi:10.1111/j.1365-2044.2007.05160.x.Google Scholar
9.Haffner, CA, Kendall, MJ. Metabolic effects of beta2-agonists. J Clin Pharm Ther 1992;17:155–64, doi:10.1111/j.1365-2710.1992.tb01285.x.CrossRefGoogle Scholar
10.Creagh-Brown, BC, Ball, J. An under-recognized complication of treatment of acute severe asthma. Am J Emerg Med 2008;26:514.e1–3, doi:10.1016/j.ajem.2007.07.035.Google Scholar
11.Salbutamol/salmeterol: lactic acidosis (first report with salmeterol) following inhalation: 2 case reports. Reactions Weekly 2010;1307:40.Google Scholar
12.Aronson, JK, editor. Corticosteroids–glucocorticoids, inhaled. In: Meyler’s side effects of drugs: the international encyclopedia of adverse drug reactions and interactions. Oxford: Department of Primary Health Care; 2006. p. 958–77.Google Scholar
13.Bustos, G, Ron, AG, Ibarra della Rosa, I, et al. Acidosis làctica secundaria a inhalacion de dosis elevadas de salbutamol. An Pediatr (Barc) 2008;69:577–92, doi:10.1016/S1695-4033(08)75243-3.Google Scholar